Literature DB >> 3359114

Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors.

S B Freedman1, E A Harley, L L Iversen.   

Abstract

1. Radioligand binding assays using [3H]-N-methylscopolamine (NMS) and [3H]-oxotremorine M (Oxo-M) have been devised to predict the efficacy of test compounds at muscarinic receptors in rat cerebral cortex. 2. Muscarinic antagonists, including non-selective and both M1- and M2-selective compounds, displayed similar affinity for both binding assays. 3. Full agonists such as carbachol and muscarine possessed a ratio of potencies against the antagonist versus the agonist ligand (NMS/Oxo-M ratio) of greater than 4000. 4. Compounds which have been shown previously to display partial agonist activity in functional assays e.g. pilocarpine and RS86 had intermediate NMS/Oxo-M ratios of 100-150. A second group of compounds which included oxotremorine had somewhat higher ratios (500-1400). 5. The ratio of affinity constants for the two assays predicted the ability of agonists to stimulate cortical phosphatidyl-inositol turnover. 6. These results suggest that the NMS/Oxo-M ratio may be a useful prediction of efficacy for novel compounds acting at cortical muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3359114      PMCID: PMC1853815          DOI: 10.1111/j.1476-5381.1988.tb11451.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  An unusual type of sympathetic ganglionic stimulant.

Authors:  A P ROSZKOWSKI
Journal:  J Pharmacol Exp Ther       Date:  1961-05       Impact factor: 4.030

2.  The character of the muscarinic receptors in different regions of the rat brain.

Authors:  N J Birdsall; E C Hulme; A Burgen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-02-13

3.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

4.  The binding of antagonists to brain muscarinic receptors.

Authors:  E C Hulme; N J Birdsall; A S Burgen; P Mehta
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

5.  The binding of agonists to brain muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  Regulation of muscarinic agonist binding by cations and guanine nucleotides.

Authors:  E C Hulme; C P Berrie; N J Birdsall; M Jameson; J M Stockton
Journal:  Eur J Pharmacol       Date:  1983-10-14       Impact factor: 4.432

8.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

9.  Muscarinic agonist binding and phospholipid turnover in brain.

Authors:  S K Fisher; P D Klinger; B W Agranoff
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

10.  Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists.

Authors:  M C Olianas; P Onali; N H Neff; E Costa
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

View more
  16 in total

1.  A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.

Authors:  S B Freedman; E A Harley; S Patel; N R Newberry; M J Gilbert; A T McKnight; J K Tang; J J Maguire; N T Mudunkotuwa; R Baker
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

2.  Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors.

Authors:  Martyn Wood; Vanessa Dubois; Dieter Scheller; Michel Gillard
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

3.  Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.

Authors:  A Newman-Tancredi; L Verrièle; M J Millan
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

4.  Mixed nicotinic and muscarinic features of cholinergic receptor coupled to secretion in bovine chromaffin cells.

Authors:  M H Shirvan; H B Pollard; E Heldman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors.

Authors:  L Daeffler; F Schmidlin; J P Gies; Y Landry
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats.

Authors:  Erasmo Nieves-Martinez; Kathryn Haynes; Steven R Childers; William E Sonntag; Michelle M Nicolle
Journal:  Behav Brain Res       Date:  2011-11-07       Impact factor: 3.332

7.  SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.

Authors:  J P Kan; R Steinberg; F Oury-Donat; J C Michaud; O Thurneyssen; J P Terranova; C Gueudet; J Souilhac; R Brodin; R Boigegrain
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.

Authors:  D J Triggle; Y W Kwon; P Abraham; M A Rahman; F I Carroll
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

9.  L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.

Authors:  R J Hargreaves; A T McKnight; K Scholey; N R Newberry; L J Street; P H Hutson; J E Semark; E A Harley; S Patel; S B Freedman
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

10.  Relationship between inhibition of cyclic AMP production in Chinese hamster ovary cells expressing the rat D2(444) receptor and antagonist/agonist binding ratios.

Authors:  E A Harley; D N Middlemiss; C I Ragan
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.